Skip to main content
CBNK
NASDAQ Finance

Capital Bancorp Q2 2026: Material Weakness Lingers, Controls Still Ineffective

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Bank Stocks · Financial
Sentiment info
Negative
Importance info
8
Price
$37.54
Mkt Cap
$611.454M
52W Low
$26.4
52W High
$38.83
52W Position info
42% above low
Off High info
3.3% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

CBNK sits 42% above its 52-week low of $26.4.

Summary

Capital Bancorp's Q2 2026 10-Q shows the previously disclosed material weakness in internal controls remains unremediated, with disclosure controls still ineffective. Remediation efforts continue but have not yet proven effective.


Key Events · Corporate Governance and Compliance · CBNK

  • Material Weakness Unremediated

    As of June 30, 2026, the material weakness in internal control over financial reporting—first revealed in the 2025 10-K—remains unremediated. Management concluded that disclosure controls and procedures were not effective.

  • Remediation Efforts Ongoing

    Control enhancements have been put in place, but management notes the controls have not operated for a sufficient period to conclude the weakness is fully remediated.

  • Financial Performance

    Net income for Q2 2026 reached $14.3 million ($0.87 per diluted share), an 8.5% increase year-over-year, while net interest income rose 6.9% to $50.9 million.

  • Dividend Increase

    Subsequent to quarter-end, the board declared a $0.14 per share dividend, a 16.7% increase from the prior quarterly dividend, payable August 26, 2026.


Analysis · CBNK · Finance

The Q2 2026 10-Q from Capital Bancorp confirms that the material weakness in internal control over financial reporting—first flagged in the 2025 10-K—has yet to be remediated. As of June 30, 2026, management acknowledges that disclosure controls and procedures were not effective. Although remediation steps are in progress, the controls haven't operated long enough to declare the weakness resolved. This persistent deficiency is a governance red flag that could erode investor confidence in the reliability of financial reporting.

At the time of this filing, CBNK was trading at $37.54 on NASDAQ in the Finance sector, with a market capitalization of approximately $611.5M. The 52-week trading range was $26.40 to $38.83. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CBNK - Latest Insights

CBNK
Jul 27, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
CBNK
Jun 17, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
CBNK
May 08, 2026, 4:11 PM EDT
Filing Type: 10-Q
Importance Score:
7
CBNK
Apr 27, 2026, 4:10 PM EDT
Source: Reuters
Importance Score:
8
CBNK
Apr 07, 2026, 4:00 PM EDT
Filing Type: DEF 14A
Importance Score:
7